The Recall Desk
HighFDA (Devices)·Z-3134-2026·Announced 2026-09-16

Nipro MedicaLyte Bicarbonate Powder Recalled for High Endotoxin Levels

Nipro Renal Solutions is recalling MedicaLyte Bicarbonate Powder due to high endotoxin levels. The recall affects 2,327 cases distributed in the US, Guatemala, and Panama.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a high-risk pathogen (endotoxin) in a medical device without reported illness, which aligns with the High severity criteria for risk-of-harm products where injury has not yet been reported.

Plain-English summary

Nipro Renal Solutions USA, Corporation is recalling 2,327 cases of MedicaLyte Bicarbonate Powder. The recall is due to the product containing high endotoxin levels. The affected product references are DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X).

The recalled product was distributed nationwide in the United States, specifically in Florida, Georgia, Illinois, Maryland, Michigan, North Carolina, New Jersey, Nevada, Ohio, and Pennsylvania. It was also distributed in Guatemala and Panama. The specific lots affected are NDB5E004 (expiration 4/30/2027), NDB5M011 (expiration 12/05/2027), and NDB4J003 (expiration 9/25/2026).

Consumers and healthcare providers should stop using the recalled product and contact Nipro Renal Solutions for further instructions or a replacement.

The recalled product

Product
MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))
Hazard
Affected units
2,327

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • NDB4J003(exp.9/25/2026)

Distribution

Distributed nationwide across the United States.

The notice also names 10 states specifically: